These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 16061

  • 1. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.
    Tsoi MS, Storb R, Weiden PL, Thomas ED.
    J Immunol; 1977 May; 118(5):1799-805. PubMed ID: 16061
    [Abstract] [Full Text] [Related]

  • 2. Canine marrow transplantation: are serum blocking factors necessary to maintain the stable chimeric state?
    Tsoi MS, Storb R, Weiden PL, Graham TC, Schroeder ML, Thomas ED.
    J Immunol; 1975 Feb; 114(2 Pt 1):531-9. PubMed ID: 1091699
    [Abstract] [Full Text] [Related]

  • 3. Graft-versus-host disease after marrow transplantation.
    Storb R.
    Prog Clin Biol Res; 1986 Feb; 224():139-57. PubMed ID: 3540990
    [Abstract] [Full Text] [Related]

  • 4. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 5. Infusion of donor lymphocytes into stable canine radiation chimeras: implications for mechanism of transplantation tolerance.
    Weiden PL, Storb R, Tsoi MS, Graham TC, Lerner KG, Thomas ED.
    J Immunol; 1976 May; 116(5):1212-9. PubMed ID: 774975
    [Abstract] [Full Text] [Related]

  • 6. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M, Khojasteh HN, Ramzi M, Haghshenas M.
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [Abstract] [Full Text] [Related]

  • 7. Bone marrow transplantation for aplastic anemia and acute leukemia at Huddinge Hospital.
    Ringdén O, Blom B, Collste H, Gahrton G, Groth CG, Grimfors G, Heimdahl A, Lundgren G, Lönnqvist B, Möller E, Pihlstedt P.
    Scand J Urol Nephrol Suppl; 1981 Dec; 64():238-45. PubMed ID: 6755685
    [Abstract] [Full Text] [Related]

  • 8. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N, Bornhäuser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schäfer-Eckardt K, Beyer J, Kiehl M, Zander AR, German Cooperative Transplant Study Group.
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [Abstract] [Full Text] [Related]

  • 9. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Devergie A, Apperley JF, Labopin M, Madrigal A, Jacobsen N, Carreras E, Prentice HG, Jouet JP, Kolb HJ, Herstenstein B, Bacigalupo A, Evensen SA, Ljungman P, de Witte T, Reiffers J, Nagler A, Clark RE, Goldman JM, Gratwohl A.
    Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
    [Abstract] [Full Text] [Related]

  • 10. [Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center].
    Schmitz N, Kayser W, Gassmann W, Euler HH, Wüstemann M, Brix F, Dühmke E, Hebbinghaus D, Gremmel H, Schaub J.
    Dtsch Med Wochenschr; 1985 Sep 27; 110(39):1488-93. PubMed ID: 3896727
    [Abstract] [Full Text] [Related]

  • 11. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
    Kusminsky G, Foncuberta MC, Aversa L, Drelichman G, Freigeiro D, Burgos R, Irrazabal C, Gonzalez G, Dictar M, Niborski R, Kohan A, Sanchez Avalos JC.
    Medicina (B Aires); 2000 Sep 27; 60(2):179-87. PubMed ID: 10962806
    [Abstract] [Full Text] [Related]

  • 12. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T, Van Lint MT, Gualandi F, Occhini D, Barbanti M, Sacchi N, Ficai G, Ghinatti C, Ferrara GB, Delfino L, Pozzi S, Morabito A, Zikos P, Vitale V, Corvo R, Frassoni F, Bacigalupo A.
    Bone Marrow Transplant; 1997 Dec 27; 20(12):1057-62. PubMed ID: 9466278
    [Abstract] [Full Text] [Related]

  • 13. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP.
    Biol Blood Marrow Transplant; 2009 Feb 27; 15(2):257-65. PubMed ID: 19167686
    [Abstract] [Full Text] [Related]

  • 14. Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival.
    Storb R, Prentice RL, Thomas ED.
    J Clin Invest; 1977 Apr 27; 59(4):625-32. PubMed ID: 14972
    [Abstract] [Full Text] [Related]

  • 15. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
    Phillips GL, Barnett MJ, Brain MC, Chan KW, Huebsch LB, Klingemann HG, Meharchand J, Reece DE, Rybka WB, Shepherd JD.
    Bone Marrow Transplant; 1991 Dec 27; 8(6):477-87. PubMed ID: 1790428
    [Abstract] [Full Text] [Related]

  • 16. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.
    J Clin Oncol; 2004 Feb 01; 22(3):416-23. PubMed ID: 14691124
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality.
    Robin M, Guardiola P, Dombret H, Baruchel A, Esperou H, Ribaud P, Devergie A, Gluckman E, Socié G.
    Bone Marrow Transplant; 2003 May 01; 31(10):877-87. PubMed ID: 12748664
    [Abstract] [Full Text] [Related]

  • 18. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    van Rhee F, Szydlo RM, Hermans J, Devergie A, Frassoni F, Arcese W, de Witte T, Kolb HJ, Niederwiser D, Jacobsen N, Gahrton G, Bandini G, Carreras E, Bacigalupo A, Michallet M, Ruutu T, Reiffers J, Goldman JM, Apperley J, Gratwohl A.
    Bone Marrow Transplant; 1997 Oct 01; 20(7):553-60. PubMed ID: 9337056
    [Abstract] [Full Text] [Related]

  • 19. HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide.
    Santos GW, Sensenbrenner LL, Anderson PN, Burke PJ, Klein DL, Slavin RE, Schacter B, Borgaonkar DS.
    Transplant Proc; 1976 Dec 01; 8(4):607-10. PubMed ID: 11591
    [No Abstract] [Full Text] [Related]

  • 20. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S.
    Haematologica; 1998 Jan 01; 83(1):48-55. PubMed ID: 9542323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.